Mednet Logo
HomeEndocrinologyQuestion

When and how should we be stopping GLP-1 Receptor Agonist/Dual Agonist therapy?

1
1 Answers
Mednet Member
Mednet Member
Endocrinology · City of Hope Comprehensive Cancer Center

I usually continue for 3-4 years, the tapering down slowly over 1 year period, buy then the set point for energy expenditure and appetite likely is changed.

Register or Sign In to see full answer

When and how should we be stopping GLP-1 Receptor Agonist/Dual Agonist therapy? | Mednet